Kruse - Pharm of Anemia Flashcards

1
Q

Tx: acute Fe toxicity

A
  • whole bowel irrigaiton

- parenteral deferoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

oral Fe chelator that reduces liver Fe concentrations

A

deferasirox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

megaloblastic macrocytic anemia

A

B12 def

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

folic acid is absorbed in the

A

jejunum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

drugs that cause folic acid def

A
  • methotrexate
  • trimethoprim
  • pyrimethamine
  • LT phenytoin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

dosing of rHuEPO

A

once weekly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

t1/2: rHuEPO

A

4-8 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

increased glycosylated form of EPO

A

darbepoetin alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

t1/2:darbepoetin alpha

A

24-26 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

increased retiulocytes d/t EPO seen in

A

10d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

rise in Hb & Hct d/t EPO seen in

A

2-6w

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

filgrastim

A

recomb human G-CSF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

t1/2: filgrastim

A

2-3.5h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pegfilgrastim

A

filgrastim + polyethylene glycol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

t1/2: pegfilgrastim

A

15-80h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

sergramostim

A

GM-CSF

17
Q

t1/2: sergramostim

A
  • IV = 1h

- subQ = 3h

18
Q

MOA: plerixafor

A

reversibly inhbits binding of stromal cell-derived factor-1-alpha

19
Q

myeloid growth factors stimulate

A

JAK/STAT signal transduction pathway

20
Q

AE: filgrastim & pegfilgrastim

A

bone pain

21
Q

peripheral edema and pleural or pericardial effusions can be indicative of what?

A

capillary leak syndrome cause by GM-CSF

22
Q

recombinant megakaryocyte growth factor approved for clinical use

A

oprelvekin

23
Q

romiplostim

A

recomb thrombopoirtin

24
Q

results of romiplostim seen in

A

5 days (post subQ) and peak at 12-15d

25
Q

t1/2: oprelvekin

A

7-8h

26
Q

tx of ppl with ITP

A

romiplostim

27
Q

AE: ferrous sulfate (Oral Fe therapy)

A
  • nausea
  • epigastric pain
  • abd cramps
  • const
  • black stools
  • diarrhea
28
Q

AE: Fe dextran

A
  • HA
  • lightheaded
  • fever
  • arthroalgias
  • N/V
  • back pain
  • flushing
  • urticaria
  • bronchospasm
  • anaphylaxis
29
Q

AE: recombinat human EPO

A
  • HTN
  • thrombotic complications
  • allergic reaction
30
Q

AE: filgrastim and pegfilgrastim

A

Bone pain

31
Q

AE: GM-CSF

A
  • fever
  • malaise
  • arthroalgias
  • myalgias
  • capillary leak syndrome
32
Q

AE: IL-11

A
  • fatigues
  • HA
  • dizziness
  • CV effects
  • hypokalemia
33
Q

AE: romiplostim

A

Mild HA

34
Q

Use in combination with filgrastim results in synergistic increase in CD34+ cell

A

Pelrixafor